Of people on the medications, 45% say they eat more vegetables, 42% say they have smaller meals, 40% have more protein and 30% have more fiber. Florian Schattenmann, chief technology officer and vice president for innovation and research and development for Cargill, Minneapolis, sees consumer adoption of GLP-1s accelerating as oral applications become more available and as intellectual property protections run out and open the door for generic brands
Novo Nordisk's brand-name pricing reflects research investment, patent protections extending until 2032, proprietary delivery devices, and insurance middleman markups
Wound and surgical recovery: Accelerated healing, reduced scarring
Both medications require consideration of kidney function, with Januvia requiring dose adjustment when eGFR falls below 45 mL/min/1.73m
Relax and unwind in our spa environment while we take care of the rest